MTNB (Matinas BioPharma Holdings, Inc.) Stock Analysis - Analyst Ratings

Matinas BioPharma Holdings, Inc. (MTNB) is a publicly traded Healthcare sector company. As of May 21, 2026, MTNB trades at $0.57 with a market cap of $3.46M and a P/E ratio of -0.30. MTNB moved +14.52% today. Year to date, MTNB is -0.64%; over the trailing twelve months it is -16.08%. Its 52-week range spans $0.47 to $4.25. Rallies surfaces MTNB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate MTNB?

The average price target is $0.00.

MTNB Key Metrics

Key financial metrics for MTNB
MetricValue
Price$0.57
Market Cap$3.46M
P/E Ratio-0.30
EPS$-2.00
Dividend Yield0.00%
52-Week High$4.25
52-Week Low$0.47
Volume1.97K
Avg Volume0
Revenue (TTM)$0
Net Income$-10.35M
Gross Margin0.00%

MTNB Analyst Consensus

MTNB analyst coverage data. Average price target: $0.00.

Latest MTNB News

Common questions about MTNB

What do analysts rate MTNB?
The average price target is $0.00.
Does Rallies show MTNB price targets?
Yes. Rallies tracks MTNB analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is MTNB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MTNB. It does not provide personalized investment advice.
MTNB

MTNB